Do we need further clinical-effectiveness estimates to support the use of primary prevention implantable cardioverter-defibrillators in New York Heart Association class III patients?
作者信息
Barra Sergio, Providencia Rui, Agarwal Sharad
机构信息
Cardiology Department, Papworth Hospital NHS Foundation Trust, Cambridge, UK.
Barts Heart Centre, Barts Health NHS Trust, London, UK.
出版信息
Int J Cardiol. 2016 Jan 15;203:184-6. doi: 10.1016/j.ijcard.2015.10.080. Epub 2015 Oct 22.
PMID:26512835
Abstract
摘要
Zotero 插件